Incidence of Postoperative Residual Neuromuscular Blockade in the Era of Sugammadex

Seoul National University

Status: Enrolling

Conditions: Postoperative Residual Curarization

Treatments: Drug: Sugammadex

Study type: Observational

Funder types: Other

Identifiers

NCT05760560

TOF-Sugammadex

Details and patient eligibility

About

This study is a prospective observational study. A total 52 patients will be included in this study. We will observe the incidence of postoperative residual neuromuscular blockade in patients receiving sugammadex.

Enrollment: 52 estimated patients

Sex: All

Ages: 19+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients undergoing elective surgery under general anesthesia.
• American Society of Anesthesiologists grade 1, 2, or 3.
• Aged >18 years

Exclusion criteria

• Refusal to participate in the study
• Body Mass Index < 18.5 kg/m2 or > 35 kg/m2
• History of neuromuscular disease.
• History of allergy to neuromuscular blockade
• Scheduled to transfer to the intensive care unit